Last $19.00 USD
Change Today +0.0396 / 0.21%
Volume 4.5K
UG On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 11:59 AM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

united guardian inc (UG) Snapshot

Open
$19.88
Previous Close
$18.96
Day High
$19.88
Day Low
$18.58
52 Week High
05/6/14 - $35.25
52 Week Low
03/5/15 - $18.58
Market Cap
87.3M
Average Volume 10 Days
4.6K
EPS TTM
$0.88
Shares Outstanding
4.6M
EX-Date
12/4/14
P/E TM
21.6x
Dividend
$0.64
Dividend Yield
4.28%
Current Stock Chart for UNITED GUARDIAN INC (UG)

Related News

No related news articles were found.

united guardian inc (UG) Related Businessweek News

No Related Businessweek News Found

united guardian inc (UG) Details

United-Guardian, Inc. researches, develops, manufactures, and markets cosmetic ingredients, personal care products, pharmaceuticals, medical and health care products, and specialty industrial products in the United States, Canada, China, France, and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; UNITWIX cosmetic additives for use as a thickener for oils and oil-based liquids; ORCHID COMPLEX, a base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 lubricants for use in cosmetics; AQUATHIK powder for use as a gelling agent for aqueous solutions or emulsions; and HYDRAJEL PL personal lubricants for the feminine personal care market. The company’s medical products comprise LUBRAJEL RR and RC lubricant gels for urinary catheters; LUBRAJEL LC mouth moisturizers for oral use; LUBRAJEL MG to lubricate urinary catheters, prelubricated enema tips, and other medical devices; LUBRAJEL FLUID to lubricate water-soluble products; LUBRAJEL BA for oral care; and LUBRAJEL TF medical lubricants. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company’s industrial products include DESELEX liquid, a sequestering and chelating agent that is a replacement for phosphates in the manufacture of detergents; and POLYCOMPLEX M and Q complexing agents to produce clear solutions of water-insoluble materials. United-Guardian, Inc. sells its products through marketing partners and distributors. The company was founded in 1942 and is headquartered in Hauppauge, New York.

33 Employees
Last Reported Date: 03/24/14
Founded in 1942

united guardian inc (UG) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $373.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $194.5K
Vice President
Total Annual Compensation: $200.1K
Compensation as of Fiscal Year 2013.

united guardian inc (UG) Key Developments

United-Guardian Announces Year-End Cash Dividend, Payable on December 22, 2014

United-Guardian Inc. announced that its board of directors, at its meeting on November 20, 2014, declared a $0.32 per share cash dividend, which will be payable on December 22, 2014 to all stockholders of record on December 8, 2014. This will be the 19th consecutive year that the company has paid a year-end dividend, and brings to $0.80 the total dividends the company has paid to its stockholders this year 2014.

United-Guardian Inc., Board Meeting, Nov 20, 2014

United-Guardian Inc., Board Meeting, Nov 20, 2014. Agenda: To consider the $0.32 per share cash dividend.

United-Guardian Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

United-Guardian Inc. announced unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company announced net sales of $2,516,620 compared to $3,404,227 for the same period a year ago. Income from operations was $543,848 compared to $1,538,522 for the same period a year ago. Income before income taxes was $594,926 compared to $1,879,091 for the same period a year ago. Net income was $411,426 compared to $1,276,791 for the same period a year ago. Earnings per common share, basic and diluted were $0.09 compared to $0.28 for the same period a year ago. The sales decreases for the third quarter and the first nine months of the year were the result of both the timing of orders from the company’s larger marketing partner for product it sells to customers in China, as well as the loss of a significant amount of business from one of that marketing partner's larger customers for one of the company’s products. For the nine months, the company announced net sales of $9,456,248 compared to $10,984,959 for the same period a year ago. Income from operations was $3,706,720 compared to $5,147,344 for the same period a year ago. Income before income taxes was $3,869,952 compared to $6,192,680 for the same period a year ago. Net income was $2,648,452 compared to $4,183,980 for the same period a year ago. Earnings per common share, basic and diluted were $0.58 compared to $0.91 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UG:US $19.00 USD +0.0396

UG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Blyth Inc $7.65 USD +0.17
CCA Industries Inc $3.19 USD -0.0294
Inter Parfums Inc $29.00 USD +0.03
Natural Health Trends Corp $14.97 USD -0.91
Stephan Co/The $1.15 USD -0.04
View Industry Companies
 

Industry Analysis

UG

Industry Average

Valuation UG Industry Range
Price/Earnings 19.7x
Price/Sales 6.2x
Price/Book 5.8x
Price/Cash Flow 19.7x
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED GUARDIAN INC, please visit www.u-g.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.